Symmetry Investments »

Taysha Gene Therapies shares owned by Symmetry Investments

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Symmetry Investments from 13F filings

Historical chart of Symmetry Investments investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Symmetry Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Symmetry Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $29k 10k 2.87

More positions owned by Symmetry Investments

Bank of America Corporation (BAC)
Hess (HES)
Microsoft Corporation (MSFT)
Ishares Bitcoin Tr SHS
Amazon (AMZN)
Select Sector Spdr Tr Energy (XLE)
Norfolk Southern (NSC)
Microstrategy Cl A New (MSTR)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation (NVDA)
Union Pacific Corporation (UNP)
Wal-Mart Stores (WMT)
TransDigm Group Incorporated (TDG)
Advanced Micro Devices (AMD)
Texas Instruments Incorporated (TXN)

View all positions for Symmetry Investments

Top funds holding Taysha Gene Therapies

FMR
RA Capital Management
VR Adviser
Vanguard Group
Morgan Stanley
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Octagon Capital Advisors
BlackRock
Damian Sousa
Cowen And Company
Susquehanna International
Point72 Asset Management

View all funds holding Taysha Gene Therapies